$ 0.44 in earnings per share expected for Endo International plc (NASDAQ: ENDP) this quarter
Analysts forecast Endo International plc (NASDAQ: ENDP) (TSE: ENL) to post earnings of $ 0.44 per share for the current quarter, Zacks reports. Four analysts made estimates for Endo International’s earnings. The highest EPS estimate is $ 0.49 and the lowest is $ 0.38. Endo International reported earnings per share of $ 0.65 in the same quarter last year, suggesting a negative year-over-year growth rate of 32.3%. The company is expected to release its next earnings report on Wednesday, August 4.
On average, analysts predict Endo International will report annual earnings of $ 2.17 per share for the current year, with EPS estimates ranging from $ 2.05 to $ 2.30. For the next fiscal year, analysts expect the company to post earnings of $ 2.07 per share, with EPS estimates ranging from $ 0.95 to $ 2.79. Zacks Investment Research’s BPA calculations are an average based on a survey of seller-side research companies that cover Endo International.
Endo International (NASDAQ: ENDP) (TSE: ENL) last released its quarterly earnings data on Thursday, May 6. The company reported EPS of $ 0.73 for the quarter, beating Thomson Reuters’ consensus estimate of $ 0.48 of $ 0.25. The company posted revenue of $ 718.00 million in the quarter, compared to a consensus estimate of $ 666.90 million. Endo International recorded a negative return on equity of 91.08% and a net margin of 3.41%. The company’s turnover is down 12.4% compared to the same quarter last year. During the same period of the previous year, the company achieved EPS of $ 0.95.
The ENDP has been the subject of a number of research analyst reports. The Royal Bank of Canada launched a cover on Endo International in a report on Wednesday April 7. They set a “sector performance” rating and a target price of $ 7.00 for the company. Morgan Stanley raised its price target on Endo International from $ 5.00 to $ 7.00 and rated the stock “underweight” in a research report published on Wednesday, March 3. TheStreet demoted Endo International from a “c” rating to a “d +” rating in a research note on Thursday, May 6. Barclays raised its price target on Endo International from $ 6.00 to $ 7.00 and gave the company an “equal weight” rating in a research note on Monday, March 8. Finally, Citigroup Inc. 3% minimum capital protected coupon based on Russell raised its price target on Endo International from $ 10.00 to $ 11.00 and assigned the company a buy rating in a rating of. search Monday May 17th. Three research analysts rated the stock with a sell rating, three assigned a conservation rating, and four assigned a buy rating to the company’s stock. Endo International currently has an average “Hold” rating and an average target price of $ 8.19.
Institutional investors and hedge funds recently bought and sold shares in the company. The Oregon Public Employees Retirement Fund increased its holdings of Endo International shares by 12.1% in the fourth quarter. The Oregon Public Employees Retirement Fund now owns 92,194 shares of the company valued at $ 662,000 after purchasing an additional 9,964 shares in the last quarter. Rhumbline Advisers increased its position in Endo International shares by 7.8% in the fourth quarter. Rhumbline Advisers now owns 592,188 shares of the company valued at $ 4,252,000 after purchasing an additional 42,676 shares in the last quarter. Alpha Paradigm Partners LLC acquired a new equity interest in Endo International in the fourth quarter valued at approximately $ 272,000. Vantage Consulting Group Inc acquired a new position in Endo International shares during the 4th quarter valued at approximately $ 89,000. Finally, Everence Capital Management Inc. purchased a new position in Endo International during the first quarter for a value of approximately $ 235,000. 80.86% of the shares are currently held by institutional investors.
NASDAQ ENDP shares traded down $ 0.09 at midday Monday, reaching $ 5.13. 140,360 shares of the company were traded, for an average volume of 3,712,225. The company has a market capitalization of $ 1.20 billion, a price / earnings ratio of 12.83 and a beta of 1.45. Endo International has a 52 week low of $ 2.71 and a 52 week high of $ 10.89. The 50-day moving average for the stock is $ 5.74.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and around the world. Its Branded Pharmaceuticals segment provides branded prescription products including XIAFLEX to treat adult patients with Dupuytren’s contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate to moderately severe pain; TESTOPEL an implantable lozenge indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM, a topical patch containing lidocaine for pain relief; and products for pain management and urology.
Read more: How is the Consumer Price Index (CPI) calculated?
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured article: How is inflation measured?
7 Internet of Things actions perfectly suited to our connected future
When you talk about the Internet of Things (IoT), you may get different answers. I like to think of it as a matter of connection. These are devices that can connect to each other and to the Internet. And it provides users with the solutions that make our life more convenient.
The most basic and ubiquitous example of an IoT device is the smartphone that many of us have with us at all times. But think about what it led to. Home assistants, security cameras, fitness apps, and more are all enabled by the Internet of Things.
The IoT took on even greater importance during the pandemic, as companies had to find a way to keep their networks secure and viable even if their employees were dispersed remotely. This has created a demand for edge and cloud computing solutions that are also facilitated by the Internet of Things.
And yes, this is just the start. The growing need for data is fueling the demand for IoT solutions in areas such as autonomous vehicles.
But the good news is that this is an area that is still very much in the growth phase. And that means there is no shortage of companies that you can find to trade in this industry. To help you get started, we’ve prepared this special presentation that highlights seven of these companies and why we think they are worth adding to your portfolio.
Consult the “7 Internet of Things Actions Perfectly Adapted to Our Connected Future”.